Diagnostics company BlinkLab seeks funds ahead of FDA submission
bestnews Diagnostics company BlinkLab seeks funds ahead of FDA submission
Healthcare & Fitness
FDA setback for Telix amid Donald Trump Food and Drug Administration cuts
Telix Pharmaceuticals says it is disappointed by a surprise US Food and Drug Administration decision to ask for more clinical evidence to support approval for its brain cancer imaging agent,…
Billion dollar medical start-ups say Trump could force a US move
Nanosonics chief executive Michael Kavanagh says the Trump administration’s tariff plans could drive the next generation of local medical manufacturing businesses to the United States unless the federal government steps…
ResMed chief executive Mick Farrell says sleep device company is exempt from Donald Trump’s tariffs
Sleep device maker ResMed says it has received an exemption from Donald Trump’s trade tariffs, meaning exports from its manufacturing hubs in Australia and Singapore can dodge the US president’s…
This $1.3b biotech is still run out of a spare bedroom in Melbourne
Apr 24, 2025 – 5.00am Gift this article Subscribe to gift this article Gift 5 articles to anyone you choose each month when you subscribe. Subscribe now Already a subscriber?…
GP salaries of $400k-plus put in spotlight by healthcare election
GP salaries of $400k-plus put in spotlight by healthcare election
Cochlear-backed Epiminder targets 2025 IPO as FDA authorisation lands
Cochlear-backed Epiminder has its sights set on an Australian initial public offering after securing Food and Drug Administration approval for its flagship Minder device. The medtech, which has spent eight…
GP earnings to top $400k a year under bulk-billing plan: Butler
GP earnings to top $400k a year under bulk-billing plan: Butler
NSW government talks tough on Healthscope, but action is a long way off
Healthscope caught the Minns government off guard last week when it offered to dissolve its joint ownership at the Northern Beaches Hospital, years before the agreement to operate the facility…
US drugs giant Eli Lilly’s warns Australia on PBS approvals
Eli Lilly says it could pull tens of millions of dollars invested in Australian clinical trials unless the federal government dramatically cuts the time it takes to put new drugs…